Table 1.

Epidemiology, etiology, and cutaneous signs seen in patients

Age/sex	Latent period	PPI	Indication of PPI	Sites	Morphology	Underlying disease
70/F	2 months	E	GERD	T+Ex+F	Annular	HTN, hyperlipidemia
60/F	6 weeks	E	Prophylaxis	T+Ex+F	Papulosquamous, target lesions	Pulmonary TB
55/M	4 weeks	E	Duodenitis	T+Ex+F	Annular	DLE
62/F	8 weeks	E	GERD	T+Ex+F	Annular	HTN, COPD
62/M	2 weeks	R	Prophylaxis	T+Ex+F	Annular	RA, HTN, COPD
53/M	4 weeks	P	Pain abdomen	T+Ex	Annular	Cirrhosis
60/M	1 year	P	Prophylaxis	T+Ex	Annular	SLE

COPD=Chronic obstructive pulmonary disease, DLE=Discoid lupus erythematous, E=Esomeprazole, Ex=extremities, F=face, GERD=Gastroesophageal reflux disease, HTN=Hypertension, P=Pantoprazole, PPI=Proton pump inhibitor, R=rabeprazole, RA=Rheumatoid arthritis, SLE=Systemic lupus erythematous, T=trunk